Syros Pharmaceuticals Stock Price To Book
| SYRSDelisted Stock | USD 0.06 0.01 10.35% |
Fundamental analysis of Syros Pharmaceuticals allows traders to better anticipate movements in Syros Pharmaceuticals' stock price by examining its financial health and performance throughout various phases of its business cycle.
Syros |
Syros Pharmaceuticals Company Price To Book Analysis
Syros Pharmaceuticals' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Syros Pharmaceuticals Price To Book | 10.65 X |
Most of Syros Pharmaceuticals' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Syros Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
CompetitionBased on the latest financial disclosure, Syros Pharmaceuticals has a Price To Book of 10.6509 times. This is 58.52% lower than that of the Biotechnology sector and 76.34% higher than that of the Health Care industry. The price to book for all United States stocks is 12.0% lower than that of the firm.
Syros Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Syros Pharmaceuticals' direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Syros Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Syros Pharmaceuticals by comparing valuation metrics of similar companies.Syros Pharmaceuticals is currently under evaluation in price to book category among its peers.
Syros Fundamentals
| Return On Equity | -7.77 | ||||
| Return On Asset | -0.6 | ||||
| Operating Margin | (288.92) % | ||||
| Current Valuation | 3.6 M | ||||
| Shares Outstanding | 26.83 M | ||||
| Shares Owned By Insiders | 0.73 % | ||||
| Shares Owned By Institutions | 33.97 % | ||||
| Number Of Shares Shorted | 913.09 K | ||||
| Price To Earning | (7.92) X | ||||
| Price To Book | 10.65 X | ||||
| Price To Sales | 13.91 X | ||||
| Revenue | 9.94 M | ||||
| Gross Profit | (88.25 M) | ||||
| EBITDA | (157.19 M) | ||||
| Net Income | (164.57 M) | ||||
| Cash And Equivalents | 244.48 M | ||||
| Cash Per Share | 12.09 X | ||||
| Total Debt | 62.08 M | ||||
| Debt To Equity | 0.49 % | ||||
| Current Ratio | 6.57 X | ||||
| Book Value Per Share | (0.41) X | ||||
| Cash Flow From Operations | (109.71 M) | ||||
| Short Ratio | 0.80 X | ||||
| Earnings Per Share | (1.80) X | ||||
| Target Price | 8.75 | ||||
| Number Of Employees | 68 | ||||
| Beta | 1.31 | ||||
| Market Capitalization | 5.37 M | ||||
| Total Asset | 168.17 M | ||||
| Retained Earnings | (722.81 M) | ||||
| Working Capital | 108.3 M | ||||
| Current Asset | 85.51 M | ||||
| Current Liabilities | 9.57 M | ||||
| Net Asset | 168.17 M |
About Syros Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Syros Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Syros Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Syros Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Syros Pink Sheet
If you are still planning to invest in Syros Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syros Pharmaceuticals' history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |